Genscript Biotech Market Cap

Genscript Biotech has a market cap or net worth of 38.65 billion as of August 15, 2025. Its market cap has increased by 38.16% in one year.

Market Cap

38.65B

Enterprise Value

39.46B

Revenue

4.62B

Ranking

n/a

PE Ratio

1.68

Stock Price

17.72

Market Cap Chart

Since December 30, 2015, Genscript Biotech's market cap has increased from 2.11B to 38.65B, an increase of 1,729.89%. That is a compound annual growth rate of 35.24%.

Market Cap History

Date	Market Cap	% Change
Aug 14, 2025	38.17B	80.92%
Dec 31, 2024	21.10B	-49.96%
Dec 29, 2023	42.16B	-19.78%
Dec 30, 2022	52.56B	-27.50%
Dec 31, 2021	72.50B	229.03%
Dec 31, 2020	22.03B	-33.64%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeOne Medicines	266.94B
Hansoh Pharmaceutical Group Company	223.44B
JD Health International	175.53B
Innovent Biologics	164.42B
Akeso	147.38B
Sino Biopharmaceutical	136.28B
WuXi Biologics	125.45B
CSPC Pharmaceutical Group	119.48B

Market Cap Rankings